| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 4 | |
| #2 | Republic of Korea | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Australia | 1 | |
| #6 | Brazil | 1 | |
| #7 | United Kingdom | 1 | |
| #8 | Japan | 1 | |
| #9 | United States | 1 | |
| #10 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zhang Yinghui | 14 |
| #2 | Luo Xiaosu | 14 |
| #3 | Xu Min | 9 |
| #4 | Zhou Xiangjun | 7 |
| #5 | Lv Wei | 6 |
| #6 | Zhang Lijie | 5 |
| #7 | Wang Yongxiang | 5 |
| #8 | Gong Nian | 5 |
| #9 | Xu Michael M | 4 |
| #10 | Lyu Wei | 3 |
| Publication | Filing date | Title |
|---|---|---|
| CN106938050A | Composition comprising GLP-1 receptor stimulating agents and glucagon receptor activator and application thereof | |
| CN106589110A | Conjugate containing polymer and GLP-2 derivative | |
| CN104277104A | Conjugate containing polymer and bioactive molecules and use thereof | |
| CN104277103A | Conjugate containing polymer and bioactive molecules and its use in fat reduction | |
| WO2010121559A1 | Novel exendin variant and conjugate thereof |